Patient Registry Software Market Report 2026

The patient registry software market size has grown rapidly in recent years. It will grow from $2.8 billion in 2025 to $3.26 billion in 2026 at a compound annual growth rate (CAGR) of 16.2%. The growth in the historic period can be attributed to manual patient data collection, fragmented healthcare databases, limited interoperability between systems, reliance on paper-based registries, slow adoption of digital health tools.

The patient registry software market size is expected to see rapid growth in the next few years. It will grow to $5.9 billion in 2030 at a compound annual growth rate (CAGR) of 16%. The growth in the forecast period can be attributed to increasing use of predictive analytics for patient outcomes, rising demand for cloud-based registries, growing emphasis on real-time population health management, expansion of integrated ehr and registry solutions, rising utilization of registries for clinical trials and research. Major trends in the forecast period include increasing adoption of ai-driven patient data analytics, rising deployment of cloud-based patient registries, growing integration of ehr and pms with registry software, increasing focus on real-time population health monitoring, rising utilization of data for clinical research and outcomes.

The growing adoption of electronic medical records (EMRs) is contributing to the expansion of the patient registry software market. An EMR is a digital version of a patient’s paper chart, supporting billing, inter-practice referrals, appointment scheduling, and medication refills. Patient registry software functionality is often integrated as an add-on within EMR and EHR systems, thereby promoting market growth. For example, in October 2024, NHS England, a UK-based public sector executive body, reported that by November 2023, 90% of trusts had adopted Electronic Patient Records (EPR) systems, enabling authorized clinicians to access critical patient information. Therefore, the increasing adoption of EMRs is expected to drive growth in the patient registry software market.

Leading companies in the patient registry software market are developing innovative solutions, such as contact registries, to better serve their users. A contact registry is a system that collects and stores contact information for a specific group of individuals, often for purposes such as emergency management, clinical trial recruitment, and disease surveillance. For instance, in November 2025, the National Organization for Rare Disorders (NORD), a US-based nonprofit supporting rare disease research, advocacy, and patient registries, launched a request for proposals (RFP) to establish new patient registries on its IAMRARE® platform. These registries aim to connect patients with rare diseases to researchers and facilitate participation in research studies. They securely collect and store contact information for individuals who wish to receive updates on rare disease research and inform participants about available studies. NORD manages these registries in collaboration with patient advocacy organizations, providing infrastructure, training, data management, and governance oversight to ensure long-term sustainability.

In October 2023, Access Healthcare, an India-based revenue cycle management (RCM) and healthcare services company, acquired Envera Health for an undisclosed amount. By integrating Envera’s patient engagement capabilities through this acquisition, Access Healthcare aims to enhance its end-to-end RCM service delivery and improve its proprietary workflows and process intelligence platform. Envera Health is a US-based human + tech engagement services company that provides an ecosystem of connectivity to strengthen health systems and physician practices.

Major companies operating in the patient registry software market are Armus Digital Pvt. Ltd., Dacima Software Inc., Evado Clinical, Global Vision Technology Co. Ltd., Gz Technology Pvt. Ltd., Healthmonix LLC, Imagetrend Inc., QVIA Holdings Inc., Lumedx Healthcare Technologies Private Limited, M2s Industries Private Limited, Mckesson Corporation, Opentext Corporation, Optum Health & Technology Private Limited, Phytel Inc., Premier Inc., Syneos Health Inc., Telligen Inc., Advarra Inc., Advera Health Analytics, ArborMetrix Inc., EResearch Technology, FIGmd Inc., Flatiron Health Inc., Healex Systems Ltd., IFA Systems AG, Liaison Technologies Inc., Medrio Inc., Molecular Corp., OM1 Inc., Open Registry, Orion Health Corp.

North America was the largest region in the patient registry software market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the patient registry software market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the patient registry software market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs have affected the patient registry software market by raising costs for imported software, cloud infrastructure, and analytics tools. Hospitals, government organizations, and research centers in north america, europe, and asia-pacific are most impacted due to dependence on global technology vendors. Increased operational costs may slow deployment of registry solutions. However, tariffs can encourage localization of software development, regional cloud services, and domestic solutions, enhancing data security and regulatory compliance.

The patient registry software market research report is one of a series of new reports that provides patient registry software market statistics, including patient registry software industry global market size, regional shares, competitors with a patient registry software market share, detailed patient registry software market segments, market trends and opportunities, and any further data you may need to thrive in the patient registry software industry. This patient registry software market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Patient registry software is a digital platform designed to collect, store, and manage detailed patient data related to specific diseases, conditions, treatments, or populations. It is used for monitoring clinical outcomes, supporting research, enhancing care coordination, and enabling data-driven decision-making in healthcare.

The primary types of patient registry software are integrated software and standalone software. Databases include disease registries, health service registries, and product registries. A disease registry is a specialized database that includes information on individuals diagnosed with a specific disease or condition, using the disease state as the inclusion criterion. Deployment models include on-premise and cloud-based solutions, offering functionalities such as population health management, patient care management, medical research and clinical studies, health information exchange, point-of-care, and product outcome evaluation. These solutions are utilized by government organizations and third-party administrators, hospitals and medical practices, private payers, pharmaceutical, biotechnology, and medical device companies, as well as research centers.

The patient registry software market consists of sales of software and services. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.